
COO, CD, EMEA, APac, Skin · COLGATE PALMOLIVE CO · Common Stock
Open-market sale
$2.0M reported value · 68.6% of prior position
Disclosed 2 business days after execution (deadline: 2)
First recorded trade by this actor in this security
2 other actors traded the same direction within 14 days
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Tsourapas PanagiotisCOO, CD, EMEA, APac, Skin | Option exercise | M | — 19.9K sh | Nov 6, 2026 traded Nov 4, 2026 | |
| 9 | Hazlin JohnChief Growth Officer | Option exercise | M | — 23.4K sh | Nov 6, 2026 traded Nov 4, 2026 | |
| 48 | Hazlin JohnChief Growth Officer | Open-market sale | SELL | $2.32M 23.4K sh | Nov 6, 2026 traded Nov 4, 2026 | |
| 44 | Wallace Noel R.Director, Chairman, President & CEO | Open-market sale | SELL | $2.01M 20.0K sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 30 | Hazlin JohnChief Growth Officer | Option exercise | M | $1.80M 23.4K sh | Nov 6, 2026 traded Nov 4, 2026 | |
| 30 | Tsourapas PanagiotisCOO, CD, EMEA, APac, Skin | Option exercise | M | $1.52M 19.9K sh | Nov 6, 2026 traded Nov 4, 2026 | |
| 16 | Kevin HernRJoint | Partial sale | SELL | $1,001 – $15K | Sep 25, 2026 traded Sep 2, 2026 | |
| 16 | Kevin HernRSelf | Partial sale | SELL | $1,001 – $15K | Sep 25, 2026 traded Aug 27, 2026 | |
| 16 | Kevin HernRSelf | Sale | SELL | $1,001 – $15K | Sep 25, 2026 traded Aug 31, 2026 | |
| 20 | Kevin HernRJoint | Sale | SELL | $1,001 – $15K | Sep 1, 2026 traded Aug 19, 2026 | |
| 39 | Julie JohnsonDJoint | Purchase | BUY | $1,001 – $15K | Aug 5, 2026 traded Sep 23, 2025 | |
| 35 | Julie JohnsonDJoint | Sale | SELL | $1,001 – $15K | Aug 5, 2026 traded Sep 23, 2025 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $1,968,708
Tsourapas Panagiotis filed this Form 4 reporting a open-market sale of CL on Nov 4, 2026. It became public on Nov 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.